Comparison of dabigatran, rivaroxaban and apixaban for effectiveness and safety in atrial fibrillation; a nationwide cohort study
Peer reviewed, Journal article
Published version
Permanent lenke
https://hdl.handle.net/11250/3066963Utgivelsesdato
2020Metadata
Vis full innførselSamlinger
- Artikler [5061]
- Publikasjoner fra CRIStin FHI [7531]